Michael Hearne

This profile gathers the share dealings of Michael Hearne in Aurinia Pharmaceuticals Inc. Between 23 March 2026 and 18 May 2026, the trades on record add up to 4 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 27 May 2026, reports a share grant in Aurinia Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 37 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.